Gefitinib-induced pyogenic granuloma in a patient with lung cancer

被引：1
|
作者：
Sahoo, Satyajeet [1 ]
Sirka, Chandra Sekhar [2 ]
Majumdar, Saroj K. Das [3 ]
Mohapatra, Prasanta Raghab [1 ]
机构：
[1] AIIMS, Dept Pulm Med & Crit Care, Bhubaneswar, Odisha, India
[2] AIIMS, Dept Dermatol & Venereol, Bhubaneswar, Odisha, India
[3] AIIMS, Dept Radiotherapy, Bhubaneswar, Odisha, India
来源：
LUNG INDIA | 2020年 / 37卷 / 01期
关键词：
D O I：
10.4103/lungindia.lungindia_277_19
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：71 / +
页数：2
相关论文
共 50 条
  • [21] Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
    Takahisa Kawamura
    Chiyo K. Imamura
    Hirotsugu Kenmotsu
    Tetsuhiko Taira
    Shota Omori
    Kazuhisa Nakashima
    Kazushige Wakuda
    Akira Ono
    Tateaki Naito
    Haruyasu Murakami
    Taisei Mushiroda
    Toshiaki Takahashi
    Yusuke Tanigawara
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 605 - 614
  • [22] Gefitinib-induced pneumonitis in non-small cell lung cancer: radiological and clinical findings in five patients
    Park, Hee Sun
    Lee, Hyun Ju
    Im, Jung-Gi
    Goo, Jin Mo
    Lee, Chang-Hyun
    Park, Chang Min
    Chun, Eun Ju
    CLINICAL IMAGING, 2007, 31 (05) : 306 - 312
  • [23] Gefitinib-induced Myositis: A Novel Case Report
    Sakamoto, Tatsuhiko
    Saito, Yoshitaka
    Takekuma, Yoh
    Kikuchi, Eiki
    Sugawara, Mitsuru
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2023, 143 (07): : 617 - 620
  • [24] Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
    Kawamura, Takahisa
    Imamura, Chiyo K.
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Mushiroda, Taisei
    Takahashi, Toshiaki
    Tanigawara, Yusuke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 605 - 614
  • [25] The cytotoxicity of gefitinib on patient-derived induced pluripotent stem cells reflects gefitinib-induced liver injury in the clinical setting
    Fujisaka, Yasuhito
    Nakagawa, Takatoshi
    Tomoda, Kiichiro
    Watanabe, Marina
    Matsunaga, Ninso
    Tamura, Yosuke
    Ikeda, Soichiro
    Imagawa, Akihisa
    Asahi, Michio
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [26] Correlation of polymorphisms of JAK and STAT with gefitinib-induced hepatotoxicity in patients with non-small cell lung cancer.
    Xin, Shuang
    Ma, Yuxiang
    Wang, Xueding
    Huang, Yan
    Zhu, Chen
    Zhao, YuanYuan
    Zhang, Li
    Huang, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Gefitinib-induced acute generalized exanthematous pustulosis in two patients with advanced non-small-cell lung cancer
    Shih, H. -C.
    Hsiao, Y. -P.
    Wu, M. F.
    Yang, J. -H.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (05) : 1101 - 1103
  • [28] Conjunctival pyogenic granuloma in a patient with chalazions
    D'Hermies, F
    Meyer, A
    Morel, X
    Halhal, M
    Elmaleh, C
    Renard, G
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2003, 26 (10): : 1085 - 1088
  • [29] Urethral pyogenic granuloma in a pediatric patient
    Carolan, Alexandra M. C.
    Batie, Shane F.
    Caldwell, Kelly M.
    Singh, Vivekanand
    Chan, Yvonne Y.
    UROLOGY CASE REPORTS, 2022, 45
  • [30] Recurrent pyogenic granuloma in a noncompliant patient
    Galos, David
    Chowdhury, Farhad R.
    Gupta, Reena
    Heman-Ackah, Yolanda D.
    Sataloff, Robert T.
    ENT-EAR NOSE & THROAT JOURNAL, 2014, 93 (01) : E32 - E33
12345